106 related articles for article (PubMed ID: 4024678)
1. [Budd-Chiari syndrome following dacarbazine therapy of malignant melanoma--an avoidable complication?].
Leyh F; Winzer M; Weber M; Hypa F
Z Hautkr; 1985 Jun; 60(12):961-72. PubMed ID: 4024678
[TBL] [Abstract][Full Text] [Related]
2. [Dacarbazine in malignant melanoma. Rare, severe side-effect: Budd-Chiari-syndrome (author's transl)].
Doering C; Pickartz H; Orfanos CE; Altenähr E
Z Hautkr; 1982 Jul; 57(13):971-80. PubMed ID: 7113323
[TBL] [Abstract][Full Text] [Related]
3. [Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome].
Balda BR; Bassermann R
MMW Munch Med Wochenschr; 1980 May; 122(21):792-4. PubMed ID: 6771598
[TBL] [Abstract][Full Text] [Related]
4. [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].
Runne U; Doepfmer K; Antz H; Groth W; FEAUX DE Lacroix W
Dtsch Med Wochenschr; 1980 Feb; 105(7):230-3. PubMed ID: 6986251
[TBL] [Abstract][Full Text] [Related]
5. [Budd-Chiari syndrome in DTIC therapy].
Swensson-Beck H; Trettel WH
Hautarzt; 1982 Jan; 33(1):30-1. PubMed ID: 7085277
[TBL] [Abstract][Full Text] [Related]
6. [DTIC: effect on fibrinolysis and thrombocyte function].
Biltz H; Budde U; Fiedler U; Harbrecht U; Kreysel HW
Onkologie; 1986 Oct; 9(5):270-3. PubMed ID: 3543778
[TBL] [Abstract][Full Text] [Related]
7. Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.
Frosch PJ; Czarnetzki BM; Macher E; Grundmann E; Gottschalk I
J Cancer Res Clin Oncol; 1979; 95(3):281-6. PubMed ID: 528568
[TBL] [Abstract][Full Text] [Related]
8. [Photosensitization with DTIC therapy in metastatic malignant melanoma].
Bolling R; Meyer-Hamme S; Schauder S
Hautarzt; 1980 Nov; 31(11):602-5. PubMed ID: 7451142
[TBL] [Abstract][Full Text] [Related]
9. Fatal hepatic vascular toxicity of DTIC. Is it really a rare event?
Ceci G; Bella M; Melissari M; Gabrielli M; Bocchi P; Cocconi G
Cancer; 1988 May; 61(10):1988-91. PubMed ID: 3359400
[TBL] [Abstract][Full Text] [Related]
10. Hepatic vascular toxicity of dacarbazine (DTIC): not a rare complication.
Marsh JC
Hepatology; 1989 May; 9(5):790-2. PubMed ID: 2707742
[No Abstract] [Full Text] [Related]
11. [Successful therapy of secondary melanoma of the orbit with DTIC].
Ballin R; Lommatzsch PK; Klöppel R
Klin Monbl Augenheilkd; 1987 Jul; 191(1):50-2. PubMed ID: 2443753
[TBL] [Abstract][Full Text] [Related]
12. [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].
Voigt H; Caselitz J; Jänner M
Klin Wochenschr; 1981 Mar; 59(5):229-36. PubMed ID: 7218735
[TBL] [Abstract][Full Text] [Related]
13. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
Carmo-Pereira J; Oliveira Costa F; Pimentel P
Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
[No Abstract] [Full Text] [Related]
14. Veno-occlusive liver disease after dacarbazine therapy (DTIC) for melanoma.
Erichsen C; Jönsson PE
J Surg Oncol; 1984 Dec; 27(4):268-70. PubMed ID: 6503301
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
Rudolf Z; Plesnicar S
Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
[TBL] [Abstract][Full Text] [Related]
16. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
[TBL] [Abstract][Full Text] [Related]
17. Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma.
Balch CM; Murray D; Presant C; Bartolucci AA
Surgery; 1984 Apr; 95(4):454-9. PubMed ID: 6369594
[TBL] [Abstract][Full Text] [Related]
18. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of malignant melanoma using DTIC].
Zaumseil RP; Fiedler H; Lübbe D
Dermatol Monatsschr; 1977 Nov; 163(11):905-14. PubMed ID: 590586
[No Abstract] [Full Text] [Related]
20. [A case of malignant melanoma responded to chemotherapy including DTIC and local injection of OK-432].
Tsuji H; Sawada S; Okano R; Shimazaki C; Nakanishi S; Haruyama H; Isemura T; Nakagawa M; Ijichi H; Ueda K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1851-5. PubMed ID: 6964031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
